NASDAQ:COCH Envoy Medical (COCH) Stock Price, News & Analysis $2.34 +0.13 (+5.88%) (As of 07/3/2024 ET) Add Compare Share Share Today's Range$2.17▼$2.4150-Day Range$2.09▼$5.1852-Week Range$0.75▼$11.72Volume6,066 shsAverage Volume18,747 shsMarket Capitalization$45.86 millionP/E RatioN/ADividend YieldN/APrice Target$7.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Envoy Medical alerts: Email Address Envoy Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside209.8% Upside$7.25 Price TargetShort InterestHealthy0.47% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.10Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.05) to ($0.90) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.20 out of 5 starsMedical Sector686th out of 896 stocksSurgical Appliances & Supplies Industry16th out of 18 stocks 3.5 Analyst's Opinion Consensus RatingEnvoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEnvoy Medical has only been the subject of 1 research reports in the past 90 days.Read more about Envoy Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.47% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Envoy Medical has recently increased by 106.76%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldEnvoy Medical does not currently pay a dividend.Dividend GrowthEnvoy Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for COCH. Previous Next 1.1 News and Social Media Coverage News SentimentEnvoy Medical has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Envoy Medical this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for COCH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Envoy Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.67% of the stock of Envoy Medical is held by insiders.Percentage Held by InstitutionsOnly 8.59% of the stock of Envoy Medical is held by institutions.Read more about Envoy Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Envoy Medical are expected to grow in the coming year, from ($1.05) to ($0.90) per share.Read more about Envoy Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Insiders ExposedHow did they achieve a perfect track record? If you want to learn how A Group of traders Made 917 Trades Without A Single Loss! And How You Could Have Consistently Beat the Market by following them...Just click this link and follow along About Envoy Medical Stock (NASDAQ:COCH)Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Read More COCH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart COCH Stock News HeadlinesJuly 1, 2024 | globenewswire.comEnvoy Medical Announces Inclusion in the Russell Microcap IndexJune 30, 2024 | americanbankingnews.comEnvoy Medical, Inc. (NASDAQ:COCH) Sees Large Increase in Short InterestJuly 5, 2024 | DTI (Ad)This could help solve one of the biggest hurdles facing traders today…There's a new trading tool that analyzes the entire stock market and provides you with confirmed Buy and Short opportunities on a silver platter.June 25, 2024 | americanbankingnews.comEnvoy Medical (NASDAQ:COCH) Receives New Coverage from Analysts at Ascendiant Capital MarketsJune 11, 2024 | globenewswire.comEnvoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for ScalingJune 6, 2024 | globenewswire.comEnvoy Medical Announces Inclusion in the MSCI USA Micro Cap IndexMay 19, 2024 | seekingalpha.comEnvoy Medical Is Pursuing Filling A Hearing Industry VoidMay 16, 2024 | investorplace.comCOCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q1 2024July 5, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…May 15, 2024 | finance.yahoo.comEnvoy Medical Reports First Quarter 2024 ResultsMay 15, 2024 | globenewswire.comEnvoy Medical Reports First Quarter 2024 ResultsApril 24, 2024 | finance.yahoo.comEnvoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024April 21, 2024 | finance.yahoo.comEnvoy Medical, Inc. (COCH)April 20, 2024 | prnewswire.comROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 17, 2024 | msn.comEnvoy Medical (COCH) Price Target Increased by 25.00% to 5.10April 17, 2024 | markets.businessinsider.comROSEN, LEADING TRIAL ATTORNEYS, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 15, 2024 | prnewswire.comCOCH LOSS ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 5, 2024 | markets.businessinsider.comROSEN, A LEADING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 3, 2024 | prnewswire.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHApril 3, 2024 | finance.yahoo.comEnvoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024April 3, 2024 | globenewswire.comEnvoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024April 3, 2024 | markets.businessinsider.comCOCH Stock Earnings: Envoy Medical Beats EPS, Beats Revenue for Q4 2023April 2, 2024 | globenewswire.comEnvoy Medical Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 29, 2024 | stockhouse.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 26, 2024 | markets.businessinsider.comROSEN, LEADING INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 24, 2024 | prnewswire.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHMarch 20, 2024 | markets.businessinsider.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCHSee More Headlines Receive COCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today7/05/2024Next Earnings (Estimated)8/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNASDAQ:COCH CUSIPN/A CIK1840877 Webwww.envoymedical.com Phone877-900-3277FaxN/AEmployees34Year FoundedN/APrice Target and Rating Average Stock Price Target$7.25 High Stock Price Target$8.50 Low Stock Price Target$6.00 Potential Upside/Downside+209.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,910,000.00 Net MarginsN/A Pretax Margin-7,718.85% Return on EquityN/A Return on Assets-112.11% Debt Debt-to-Equity RatioN/A Current Ratio1.10 Quick Ratio0.90 Sales & Book Value Annual Sales$320,000.00 Price / Sales143.33 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / Book-26.00Miscellaneous Outstanding Shares19,600,000Free Float19,469,000Market Cap$45.86 million OptionableNot Optionable Beta2.29 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Brent T. Lucas Esq. (Age 41)CEO & Director Comp: $303.66kMr. David R. Wells (Age 62)Chief Financial Officer Comp: $283.77kKey CompetitorsLakeland IndustriesNASDAQ:LAKEAlpha Pro TechNYSE:APTNutribandNASDAQ:NTRBCollPlant BiotechnologiesNASDAQ:CLGNMilestone ScientificNYSE:MLSSView All CompetitorsInsiders & InstitutionsVirtu Financial LLCBought 14,045 shares on 5/20/2024Ownership: 0.072%WealthTrust Asset Management LLCBought 11,316 shares on 5/3/2024Ownership: 0.058%Brent T LucasBought 12,380 shares on 11/21/2023Total: $12,008.60 ($0.97/share)View All Insider TransactionsView All Institutional Transactions COCH Stock Analysis - Frequently Asked Questions Should I buy or sell Envoy Medical stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Envoy Medical in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" COCH shares. View COCH analyst ratings or view top-rated stocks. What is Envoy Medical's stock price target for 2024? 3 equities research analysts have issued twelve-month price objectives for Envoy Medical's stock. Their COCH share price targets range from $6.00 to $8.50. On average, they predict the company's stock price to reach $7.25 in the next twelve months. This suggests a possible upside of 209.8% from the stock's current price. View analysts price targets for COCH or view top-rated stocks among Wall Street analysts. How have COCH shares performed in 2024? Envoy Medical's stock was trading at $1.8106 at the beginning of 2024. Since then, COCH shares have increased by 29.2% and is now trading at $2.34. View the best growth stocks for 2024 here. Are investors shorting Envoy Medical? Envoy Medical saw a increase in short interest in June. As of June 15th, there was short interest totaling 30,600 shares, an increase of 106.8% from the May 31st total of 14,800 shares. Based on an average trading volume of 67,700 shares, the days-to-cover ratio is presently 0.5 days. Approximately 0.5% of the shares of the stock are short sold. View Envoy Medical's Short Interest. When is Envoy Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 21st 2024. View our COCH earnings forecast. How were Envoy Medical's earnings last quarter? Envoy Medical, Inc. (NASDAQ:COCH) announced its earnings results on Wednesday, May, 15th. The company reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.19) by $0.13. The firm earned $0.06 million during the quarter, compared to the consensus estimate of $0.08 million. How do I buy shares of Envoy Medical? Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:COCH) was last updated on 7/5/2024 by MarketBeat.com Staff From Our PartnersObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredGet in before Reddit doesRobinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
